KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001827505-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
100,000
Total Value
$0.00
P&L
+inf% (+$1,643,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Restricted Stock Unit | Derivative | Jan 16, 2026 | Grant/Award | 100,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details |